US Oncology Reports Second Quarter Operating Results
HOUSTON, Aug. 6 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), one of the nation's largest cancer care services companies, reported revenue of $881.6 million, EBITDA of $39.9 million, Adjusted EBITDA of $62.7 million, net loss of $7.6 million and operating cash ...
US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board
THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- Today, the Board of Directors of US
Oncology Holdings, Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US Oncology" or the "Company"), announced that, effective Sept. 1, 2009, R. Dale Ross is retiring as Executive Chair...
Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
FRAZER, Pa., Aug. 3 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) today announced that the Journal of Clinical
Oncology has published data from a pivotal phase 3 study demonstrating that TREANDA(R) (bendamustine HCl) for Injection improved clinical outcomes when compared to chl...
Tampa Bay Radiation Oncology Announces New Full Service Center at Bruce B Downs
TAMPA, Fla., July 29 /PRNewswire/ -- (Tampa Bay Radiation Oncology, Tampa, FL) - It is with great excitement and enthusiasm that Tampa Bay Radiation
Oncology announces the grand opening of their new full service radiation
oncology center on August 17, 2009. Located at 12206 Bruce...
The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients
WASHINGTON, July 23 /PRNewswire/ -- The Community
Oncology Alliance (COA), a national non-profit organization of oncologists that advocates for cancer patients and community providers of cancer care, has responded in a public statement to President Obama's press conference, saying:
...
PRA International to Host Audio Conference: Oncology Trials in 2009 - Challenges & Innovative Approaches
RALEIGH, N.C., July 22 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host an audio conference entitled "Oncology Trials in 2009 - Challenges & Innovative Approaches" on July 28, 2009. In this audio conference, Dr. Ute Berger, Vice President and He...
US Oncology to Report 2009 Second Quarter Operating Results
HOUSTON, July 21 /PRNewswire/ -- US Oncology, Inc. will announce its financial results for the second quarter of fiscal 2009 on Thursday, August 6, 2009.
A conference call and simultaneous webcast will be hosted by management at 11 a.m. ET following distribution of the earn...
US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
THE WOODLANDS, Texas, July 20 /PRNewswire/ -- US Oncology, Inc . today announced that US
Oncology Research will participate in the BiPar Sciences' Phase III, Multi-center, Open-Label, Randomized Trial of Gemcitabine/Carboplatin (G/C), with or without BSI-201, in p...
Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective
BOSTON, July 9 /PRNewswire-FirstCall/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced that it has enhanced its capabilities with respect to processing and analysis of medical images for centr...
MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
ATLANTA, June 24 /PRNewswire/ -- MDOUTLOOK(R), the innovative
oncology intelligence platform, today announced the results from its Quick Poll research, which was launched immediately following this month's annual meeting of the American Society of Clinical
Oncology (ASCO) in Orlando, Florida. Base...
US Oncology Offers Electronic Health Records Informative Webinar
Medicare HIT Incentives for the Community
Oncology Practices
THE WOODLANDS, Texas, June 23 /PRNewswire/ --
WHO: Community oncologists, practice administrators, executive
directors, nurses and other community
oncology staff
WHAT: Informative Webina...
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
AMSTERDAM, June 18 /PRNewswire-FirstCall/ -- Doctors in the Netherlands have developed new ways to perform radiosurgery on benign acoustic tumors using fast and precise RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR ). This is among the findings in several papers pub...
US Oncology Launches Oncology-Specific EHR to the Open Market
iKnowMed now available to community-based
oncology practices
HOUSTON, June 10 /PRNewswire/ -- Today US Oncology, Inc ., supporting the nation's foremost cancer treatment and research network and working with physicians, manufacturers and payers to advance cancer care in America, announces ...
Aptium Oncology Names New Chief Operating Officer
Paul O'Dea, VP and Executive Director of Cedars-Sinai Outpatient Cancer Center Appointed COO
LOS ANGELES, June 8 /PRNewswire-USNewswire/ -- Aptium
Oncology today announced the appointment of Paul R. O'Dea to the position of Chief Operating Officer (COO). O'Dea was formerly Vice President, A...
Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer
RARITAN, N.J., June 4 /PRNewswire/ -- Ortho Biotech
Oncology Research & Development, a unit of Centocor Research & Development, Inc., today announced that it has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), with S...
Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting
New Product Names for Recently Introduced MicroRNA-based Diagnostics Also Unveiled
SAN DIEGO, June 1 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, presented an overview of its proprietary
oncology diagnostic platform yesterday at the American...
MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
SCOTTSDALE, Ariz., May 30 /PRNewswire/ -- MedTrust Online LLC simultaneously announced today that it has completed a second round of financing, released a more powerful search engine for
Oncology as a Dell eHealthcare Architecture partner, and added another world class oncologist to its Advisory B...
Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
A pilot study of a new productivity tool developed by the National Comprehensive Cancer Network (NCCN) shows potential in measuring the impact of mid-level
oncology providers in outpatient
oncology settings. Refining productivity metrics for this group can help inform workforce projec...
PRA International Oncology Experts at ASCO
RALEIGH, N.C., May 29 /PRNewswire/ -- PRA International, a leading Clinical Research Organization with expertise in Oncology, recently hosted an
Oncology audioconference and announces it will exhibit at the 2009 American Society of Clinical
Oncology (ASCO) meeting in Orlando, Florida, May 30 t...
Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle
With the recent news that one in three common cancers may be preventable, adopting a healthy lifestyle is more important than ever. Texans may find it is easier in summer to change their lifestyles than during busier times of the year. Texas
Oncology suggests four simple steps to
improve overall ...
Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
SAN FRANCISCO, May 21 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that additional clinical results from a Phase 1-2 clinical trial involving 140 men with advanced prostate cancer evaluating MDV3100, a next-generation androgen receptor antagonist, will be presented ...
Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
REDWOOD CITY, Calif., May 21 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that the company will present results from three studies at the American Society of Clinical
Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Conven...
Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
Preclinical Study is Subject of Upcoming ASCO Presentation
BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence that the company's novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance a...
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
OSAKA, Japan, and IRVINE, Calif., May 18 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited (TSE: 4502) and IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that Takeda America Holdings, Inc., a wholly-owned subsidiary of Takeda (Takeda America), and IDM Pharma have enter...
BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that updated survival data from its Phase II study in metastatic melanoma will be presented at the 2009 American Societ...
US Oncology Commends Governor Sebelius' Confirmation as U.S. Secretary of Health and Human Services
Kansas Governor a Strong Choice Due to Experience in Navigating Complex Health Care Access Issues, Working Across Party Lines to Promote Reform
WASHINGTON, April 28 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the nation's largest cancer treatment and research networks ...
Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
ANN ARBOR, Mich., April 28 /PRNewswire/ -- Compendia Bioscience today announced a strategic collaboration with MDS Pharma Services to deliver OncoPredictor(SM) -- a novel solution for improved cancer drug development. OncoPredictor(SM) combines MDS Pharma Services OncoPanel(TM) with Compendia Bio...
Pharmatech Oncology Launches New Data Management Business Unit
DENVER, April 24 /PRNewswire/ -- Pharmatech Oncology, Inc., a Research Management Organization (RMO) headquartered in Denver, Colorado, announces the launch of their Data Management business unit to the bioscience and pharmaceutical industries. The Pharmatech
Oncology Data Management business uni...
US Oncology Wins Three National Safety Council Awards
Texas Chapter Recognizes Pharmaceutical Distribution Center , Specialty Pharmacy and Research Network
HOUSTON, March 30 /PRNewswire/ -- Three US Oncology, Inc . businesses have received a Safety Excellence Perfect Record Award in the Occupational Safety & Health catego...
Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
PRINCETON, N.J., March 26 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that Dr. Geoffrey M. Nichol, Senior Vice President of Product Development at Medarex presented highlights from key programs in Medarex's
oncology portfolio at the Needham & Company Cancer Therap...
Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
SOUTH SAN FRANCISCO, Calif., March 20 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that it will concentrate its cash resources on the clinical and commercial development of its late-stage
oncology candid...
Radiation Oncology Institute (ROI) Campaign Raises $7 Million
Elekta pledges $1 million toward $10 million campaign goal
FAIRFAX, Va., March 17 /PRNewswire-USNewswire/ -- The newly formed Radiation
Oncology Institute (ROI) has so far raised $7 million as part of its initial campaign goal and is on target to achieve its $10 million campaign goal. This in...
House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill
WASHINGTON, March 10 /PRNewswire-USNewswire/ -- Representatives Gene Green (D-TX), Ed Whitfield (R-KY), Mike Ross (D-AR), Ed Towns (D-NY), Diana DeGette (D-CO), Mike Rogers (R-MI), Betty Sutton (D-OH), Bart Gordon (D-TN), Lee Terry (R-NE) and Ralph Hall (R-TX) today introduced H.R. 1392.
...
ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
MEMPHIS, Tenn., March 2 /PRNewswire-USNewswire/ -- Accelerated Community
Oncology Research Network (ACORN(TM)), an
oncology focused research network, announced today the highlights of its annual Principal Investigators' Meeting held in Scottsdale, AZ in February. Medical oncologists from communit...
US Oncology Reports Fourth Quarter and Yearend 2008 Results
HOUSTON, Feb. 26 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the
Company"), one of the nation's largest cancer care services companies,
reported revenue of $842.7 million, EBITDA of $52.3 million, Adjusted EBITDA
of $55.2 million, net income of $0.5 million and operating cash flow of ...
Molecular Oncology accepted into Thomson Reuters index
Amsterdam, 25 February 2009 Molecular
Oncology (MOLONC) ( http://www.elsevier.com/locate/molonc ), published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS), has been accepted by Thomson Reuters (formerly ISI), for inclusion in the Science Citation Index Expand...
SwedishAmerican Hospital and Precyse Solutions Sign Major Outsourced Oncology Data Management Agreement
WAYNE, Pa., Feb. 24 /PRNewswire/ -- Precyse Solutions, a leading provider of clinical documentation software, workflow tools and consulting services, has signed a five-year
Oncology Data Management contract with SwedishAmerican Hospital in Rockford, IL. The agreement between Precyse and SwedishAm...
Healthcare Businesswomen's Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company
-- Event Marks 20th Anniversary of the HBA's Prestigious Industry Award --
FAIRFIELD, N.J., Feb. 17 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) today announced that its 2009 "Woman of the Year" is Dr. Deborah Dunsire, President and Chief Executive Officer of M...
US Oncology to Report 2008 Fourth Quarter Earnings Results
HOUSTON, Feb. 13 /PRNewswire/ -- US Oncology, Inc., will announce 2008 fourth quarter financial results on Thursday, February 26, 2009.
A conference call and simultaneous webcast has been scheduled at 11 a.m., EST, for the company's bondholders following the distribution of the news release. ...
Australia's Leading Oncology Drug Compounder Chooses RIVA System
WINNIPEG, Feb. 11 /PRNewswire/ - Pharmatel Fresenius Kabi Pty Ltd, one of Australia's fastest growing and most innovative pharmaceutical companies, has chosen the RIVA System (Robotic IV Automation) - a self-contained unit for filling IV syringes and bags - from Intelligent Hospital Systems (IH Sy...